The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Iatrogenic Creutzfeldt-Jakob Disease, Final Assessment
Open accessAbstract
The era of iatrogenic Creutzfeldt-Jakob disease (CJD) has nearly closed; only occasional cases with exceptionally long incubation periods are still appearing. The principal sources of these outbreaks are contaminated growth hormone (226 cases) and dura mater grafts (228 cases) derived from human cadavers with undiagnosed CJD infections; a small number of additional cases are caused by neurosurgical instrument contamination, corneal grafts, gonadotrophic hormone, and secondary infection with variant CJD transmitted by transfusion of blood products. No new sources of disease have been identified, and current practices, which combine improved recognition of potentially infected persons with new disinfection methods for fragile surgical instruments and biological products, should continue to minimize the risk for iatrogenic disease until a blood screening test for the detection of preclinical infection is validated for human use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Letter: Possible person-to-person transmission of Creutzfeldt-Jakob disease.
Duffy, P. E., Wolf, J., Collins, G., et al. (1974) · PubMed · Cited by 529
Mortality from Creutzfeldt–Jakob disease and related disorders in Europe, Australia, and Canada
Ladogana, A., Puopolo, M., Croes, E. A., Budka, H., Jarius, C., Collins, S., Klug, G. M., Sutcliffe, T., Giulivi, A., Alperovitch, A., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000160117.56690.b2 · Cited by 387
Self-citationPossible Person-to-Person Transmission of Creutzfeldt-Jakob Disease
(1974) · New England Journal of Medicine · doi:10.1056/nejm197403212901220 · Cited by 364
Novel methods for disinfection of prion-contaminated medical devices
Fichet, G., Comoy, E., Duval, C., Antloga, K., Dehen, C., Charbonnier, A., McDonnell, G., Brown, P., Ida Lasmézas, C., & Deslys, J.-P. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16810-4 · Cited by 253
Self-citationIatrogenic Creutzfeldt–Jakob disease: The waning of an era
Brown, P., Brandel, J.-P., Preese, M., & Sato, T. (2006) · Neurology · doi:10.1212/01.wnl.0000231528.65069.3f · Cited by 207
Self-citationProspective 10-year surveillance of human prion diseases in Japan
Nozaki, I., Hamaguchi, T., Sanjo, N., Noguchi-Shinohara, M., Sakai, K., Nakamura, Y., Sato, T., Kitamoto, T., Mizusawa, H., Moriwaka, F., et al. (2010) · Brain · doi:10.1093/brain/awq216 · Cited by 198
Self-citationDistribution of codon 129 genotype in human growth hormone-treated CJD patients in France and the UK
Brandel, J., Preece, M. A., Brown, P., Croes, E. A., Laplanche, J., Agid, Y., Will, R. G., & Alpérovitch, A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13867-6 · Cited by 120
Self-citationDoh‐ura, K., Kitamoto, T., Sakaki, Y., & Tateishi, J. (1991) · Nature · doi:10.1038/353801b0 · Cited by 119
Prion inactivation using a new gaseous hydrogen peroxide sterilisation process
Fichet, G., Antloga, K., Comoy, E. E., Deslys, J.-P., & McDonnell, G. E. (2007) · Journal of Hospital Infection · doi:10.1016/j.jhin.2007.08.020 · Cited by 102
New generation QuIC assays for prion seeding activity
Orru, C. D., Wilham, J. M., Vascellari, S., Hughson, A. G., & Caughey, B. W. (2012) · Prion · doi:10.4161/pri.19430 · Cited by 101
Cited by
Self-propagation of pathogenic protein aggregates in neurodegenerative diseases
Jucker, M., & Walker, L. C. (2013) · Nature · doi:10.1038/nature12481 · Cited by 1,663
Evidence for human transmission of amyloid-β pathology and cerebral amyloid angiopathy
Jaunmuktane, Z., Mead, S., Ellis, M., Wadsworth, J. D. F., Nicoll, A. J., Kenny, J., Launchbury, F., Linehan, J., Richard-Loendt, A., Walker, A. S., et al. (2015) · Nature · doi:10.1038/nature15369 · Cited by 518
Propagation and spread of pathogenic protein assemblies in neurodegenerative diseases
Jucker, M., & Walker, L. C. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0238-6 · Cited by 450
Neurodegenerative Diseases: Expanding the Prion Concept
Walker, L. C., & Jucker, M. (2015) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-071714-033828 · Cited by 361
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript infection with BSE prions has largely passed, and as a result of improved understanding of prions, infectious prion disease in humans has essentially disappeared (Brown et al. 2012).”
A Test for Creutzfeldt–Jakob Disease Using Nasal Brushings
Orrú, C. D., Bongianni, M., Tonoli, G., Ferrari, S., Hughson, A. G., Groveman, B. R., Fiorini, M., Pocchiari, M., Monaco, S., Caughey, B., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1315200 · Cited by 355
Self-citationGrowth hormone — past, present and future
Ranke, M. B., & Wit, J. M. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2018.22 · Cited by 346
Like prions: the propagation of aggregated tau and α-synuclein in neurodegeneration
Goedert, M., Masuda-Suzukake, M., & Falcon, B. (2017) · Brain · doi:10.1093/brain/aww230 · Cited by 323
Uttley, L., Carroll, C., Wong, R., Hilton, D. A., & Stevenson, M. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30615-2 · Cited by 258
Neuroinvasion of α-Synuclein Prionoids after Intraperitoneal and Intraglossal Inoculation
Breid, S., Bernis, M. E., Babila, J. T., Garza, M. C., Wille, H., & Tamgüney, G. (2016) · Journal of Virology · doi:10.1128/jvi.01399-16 · Cited by 103
Ugalde, C. L., Finkelstein, D. I., Lawson, V. A., & Hill, A. F. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13772 · Cited by 92
Metadata
- Authors
- Brown, P., Brandel, J.-P., Sato, T., Nakamura, Y., MacKenzie, J., Will, R. G., Ladogana, A., Pocchiari, M., Leschek, E. W., & Schonberger, L. B.
- Venue
- Emerging Infectious Diseases
- Published
- 2012-06
- Volume
- 18
- Issue
- 6
- Pages
- 901-907
- ISSN
- 1080-6040 (ISSN-L)
- 1080-6059
- OpenAlex
- W2079304641
- Cited by
- 361
- References
- 15
- FWCI
- 10.11
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.